To access the full text documents, please follow this link: http://hdl.handle.net/2445/117402
dc.contributor | Universitat de Barcelona |
---|---|
dc.contributor.author | Zhu, Andrew X. |
dc.contributor.author | Rosmorduc, Olivier |
dc.contributor.author | Evans, T.R. Jeffry |
dc.contributor.author | Ross, Paul J. |
dc.contributor.author | Santoro, Armando |
dc.contributor.author | Carrilho, Flair Jose |
dc.contributor.author | Bruix Tudó, Jordi |
dc.contributor.author | Qin, Shukui |
dc.contributor.author | Thuluvath, Paul J. |
dc.contributor.author | Llovet i Bayer, Josep Maria |
dc.contributor.author | Leberre, Marie-Aude |
dc.contributor.author | Jensen, Markus |
dc.contributor.author | Meinhardt, Gerold |
dc.contributor.author | Kang, Yoon-Koo |
dc.date | 2017-11-06T10:56:54Z |
dc.date | 2017-11-06T10:56:54Z |
dc.date | 2014-02-20 |
dc.date | 2017-11-06T10:56:54Z |
dc.identifier.citation | 0732-183X |
dc.identifier.citation | 649304 |
dc.identifier.uri | http://hdl.handle.net/2445/117402 |
dc.format | 8 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | American Society of Clinical Oncology |
dc.relation | Reproducció del document publicat a: https://doi.org/10.1200/JCO.2013.53.7746 |
dc.relation | Journal of Clinical Oncology, 2014, vol. 33, num. 6, p. 559-566 |
dc.relation | https://doi.org/10.1200/JCO.2013.53.7746 |
dc.rights | (c) American Society of Clinical Oncology, 2014 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.subject | Càncer de fetge |
dc.subject | Quimioteràpia |
dc.subject | Assaigs clínics de medicaments |
dc.subject | Placebos |
dc.subject | Liver cancer |
dc.subject | Chemotherapy |
dc.subject | Drug testing |
dc.subject | Placebos (Medicine) |
dc.title | Search: A phase III, randomized, double-blind, placebo-controlled trial of sorafenib plus erlotinib in patients with advanced hepatocellular carcinoma |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract |